Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Mallinckrodt
Merck
Argus Health
Covington
UBS
McKesson
Accenture
Cantor Fitzgerald

Generated: April 24, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 012787

« Back to Dashboard

NDA 012787 describes SYNALAR, which is a drug marketed by Medimetriks Pharms and is included in four NDAs. It is available from two suppliers. Additional details are available on the SYNALAR profile page.

The generic ingredient in SYNALAR is fluocinolone acetonide. There are twelve drug master file entries for this compound. Nineteen suppliers are listed for this compound. Additional details are available on the fluocinolone acetonide profile page.
Summary for 012787
Pharmacology for NDA: 012787
Medical Subject Heading (MeSH) Categories for 012787
Suppliers and Packaging for NDA: 012787
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787 NDA Medimetriks Pharmaceuticals, Inc. 43538-900 N 43538-900-12
SYNALAR fluocinolone acetonide CREAM;TOPICAL 012787 NDA Medimetriks Pharmaceuticals, Inc. 43538-900 N 43538-900-99

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Profile for product number 004

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.01%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Profile for product number 005

Active Rx/OTC/Discontinued:RXDosage:CREAM;TOPICALStrength0.025%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Deloitte
US Army
Cipla
AstraZeneca
Cantor Fitzgerald
Johnson and Johnson
Medtronic
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.